Dr. Mitchell B. Strominger, M.D.
Ophthalmology (Neuro-ophthalmology Physician)
1500 E 2nd St Ste 300
Reno, NV 89502
Who else practices at this address →
Washoe County includes primary care (2% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- Washington University School of Medicine (1986)
- Years since graduation
- 40
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 141
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1986Medical school: Washington University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Neuro-ophthalmology Physician primary
NV license 18310 -
Ophthalmology Physician
MA license 211857 · NV license 18310
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Renown Regional Medical Center Reno, NV
Medical groups
- Community Care Services LLC (641 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 141
- Services billed
- 472
- Patients’ average age
- 73
| Service | Times | Patients |
|---|---|---|
| Photography of the retina | 223 | 168 |
| Established patient office or other outpatient visit, 30-39 minutes | 123 | 89 |
| Exam to measure eye deviation and range of motion | 100 | 71 |
| New patient office or other outpatient visit, 60-74 minutes | 72 | 72 |
| Established patient office or other outpatient visit, 20-29 minutes | 47 | 43 |
| New patient office or other outpatient visit, 45-59 minutes | 27 | 27 |
| Exam of visual field with extended testing | 26 | 26 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Methotrexate (methotrexate sodium) Other prescribers in Reno, NV | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 5 companies reported 24 payments worth $11,570 in total to this clinician.
| Amgen Inc. | $11,222 |
|---|---|
| Pfizer Inc. | $132 |
| UCB, Inc. | $125 |
| Dompe US, Inc. | $65.73 |
| Argenx US, Inc. | $24.91 |
| Compensation for services other than consulting (speaking, faculty) | $9,975 |
|---|---|
| Food and Beverage | $1,077 |
| Travel and Lodging | $518 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Amgen Inc. Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $3,150 |
| Amgen Inc. Sep 16, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $3,150 |
| Amgen Inc. Mar 10, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $2,625 |
| Amgen Inc. Oct 15, 2025 | Compensation for services other than consulting (speaking, faculty) TEPEZZA · Inflammation/Rare Disease | $1,050 |
| Amgen Inc. Sep 25, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to Las Vegas, NV · in-kind | $495 |
| Amgen Inc. Oct 16, 2025 | Travel and Lodging TEPEZZA · Inflammation/Rare Disease · travel to Las Vegas, NV | $22.81 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.